<?xml version="1.0" ?>
<GlossaryTerm id="CDR0000321388">
  <TermName>soblidotin</TermName>
  <TermPronunciation>(soh-blih-DOH-tin)</TermPronunciation>
  <TermDefinition>
    <DefinitionText>A substance being studied in the treatment of cancer. It is a type of tubulin inhibitor. Also called TZT-1027.</DefinitionText>
    <Dictionary>Cancer.gov</Dictionary>
    <Audience>Patient</Audience>
  </TermDefinition>
  <MediaLink ref="CDR0000731824" type="audio/mpeg" alt="Pronunciation of dictionary term &quot;soblidotin&quot;" language="en" id="_3"/>
  <MediaLink ref="CDR0000731825" type="audio/mpeg" alt="Pronunciation of dictionary term &quot;soblidotina&quot;" language="es" id="_4"/>
  <SpanishTermName>soblidotina</SpanishTermName>
  <SpanishTermDefinition>
    <DefinitionText>Sustancia en estudio para el tratamiento del cáncer. Es un tipo de inhibidor de la tubulina. También se llama TZT-1027.</DefinitionText>
    <Dictionary>Cancer.gov</Dictionary>
    <Audience>Patient</Audience>
  </SpanishTermDefinition>
  <DateFirstPublished>2003-07-26</DateFirstPublished>
  <DateLastModified>2008-11-21</DateLastModified>
</GlossaryTerm>
